Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT GLENMARK PHARMA WOCKHARDT/
GLENMARK PHARMA
 
P/E (TTM) x -15.8 -31.4 - View Chart
P/BV x 2.5 2.9 88.2% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 WOCKHARDT   GLENMARK PHARMA
EQUITY SHARE DATA
    WOCKHARDT
Mar-23
GLENMARK PHARMA
Mar-23
WOCKHARDT/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs316487 64.8%   
Low Rs145349 41.7%   
Sales per share (Unadj.) Rs184.0460.4 40.0%  
Earnings per share (Unadj.) Rs-43.113.4 -322.2%  
Cash flow per share (Unadj.) Rs-25.735.0 -73.3%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs231.7335.1 69.1%  
Shares outstanding (eoy) m144.09282.17 51.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30.9 137.9%   
Avg P/E ratio x-5.331.3 -17.1%  
P/CF ratio (eoy) x-9.011.9 -75.2%  
Price / Book Value ratio x1.01.2 79.7%  
Dividend payout %018.7 -0.0%   
Avg Mkt Cap Rs m33,202117,953 28.1%   
No. of employees `000NANA-   
Total wages/salary Rs m6,37027,810 22.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m26,510129,901 20.4%  
Other income Rs m1,2203,168 38.5%   
Total revenues Rs m27,730133,069 20.8%   
Gross profit Rs m-1,93015,125 -12.8%  
Depreciation Rs m2,5106,113 41.1%   
Interest Rs m3,0203,496 86.4%   
Profit before tax Rs m-6,2408,685 -71.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-304,911 -0.6%   
Profit after tax Rs m-6,2103,774 -164.5%  
Gross profit margin %-7.311.6 -62.5%  
Effective tax rate %0.556.5 0.9%   
Net profit margin %-23.42.9 -806.3%  
BALANCE SHEET DATA
Current assets Rs m19,14098,737 19.4%   
Current liabilities Rs m34,35050,455 68.1%   
Net working cap to sales %-57.437.2 -154.4%  
Current ratio x0.62.0 28.5%  
Inventory Days Days397 587.8%  
Debtors Days Days11115 9.5%  
Net fixed assets Rs m48,67076,920 63.3%   
Share capital Rs m720282 255.2%   
"Free" reserves Rs m32,66094,281 34.6%   
Net worth Rs m33,38094,563 35.3%   
Long term debt Rs m2,24038,521 5.8%   
Total assets Rs m70,750175,658 40.3%  
Interest coverage x-1.13.5 -30.6%   
Debt to equity ratio x0.10.4 16.5%  
Sales to assets ratio x0.40.7 50.7%   
Return on assets %-4.54.1 -108.9%  
Return on equity %-18.64.0 -466.1%  
Return on capital %-9.09.2 -98.8%  
Exports to sales %00-   
Imports to sales %3.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m920NA-   
Fx inflow Rs m73046,464 1.6%   
Fx outflow Rs m92012,712 7.2%   
Net fx Rs m-19033,751 -0.6%   
CASH FLOW
From Operations Rs m1,5306,254 24.5%  
From Investments Rs m-1,250-5,285 23.7%  
From Financial Activity Rs m-3,150-775 406.7%  
Net Cashflow Rs m-2,800325 -861.5%  

Share Holding

Indian Promoters % 54.9 46.7 117.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.5 34.7 12.9%  
FIIs % 4.2 23.7 17.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 45.1 53.4 84.5%  
Shareholders   161,813 209,931 77.1%  
Pledged promoter(s) holding % 74.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Wockhardt vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Wockhardt vs Glenmark Pharma Share Price Performance

Period Wockhardt Glenmark Pharma S&P BSE HEALTHCARE
1-Day 4.99% -0.57% 1.18%
1-Month 0.15% 5.16% -0.75%
1-Year 290.07% 112.94% 61.82%
3-Year CAGR 13.79% 27.51% 18.16%
5-Year CAGR 7.92% 8.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the Wockhardt share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of Wockhardt hold a 54.9% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Wockhardt and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, Wockhardt paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of Wockhardt, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.